XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 36 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $531,000 | -39.2% | 216,882 | +1.0% | 0.00% | – |
Q2 2021 | $874,000 | -75.3% | 214,682 | -72.6% | 0.00% | – |
Q1 2021 | $3,538,000 | -6.4% | 784,539 | +2.1% | 0.00% | – |
Q4 2020 | $3,779,000 | -5.7% | 768,079 | +13.7% | 0.00% | – |
Q3 2020 | $4,006,000 | +143.1% | 675,559 | +9.1% | 0.00% | – |
Q2 2020 | $1,648,000 | +55.9% | 619,398 | +14.3% | 0.00% | – |
Q1 2020 | $1,057,000 | -70.0% | 542,031 | +8.3% | 0.00% | – |
Q4 2019 | $3,528,000 | -23.1% | 500,401 | +7.3% | 0.00% | – |
Q3 2019 | $4,585,000 | +0.5% | 466,451 | +17.0% | 0.00% | – |
Q2 2019 | $4,560,000 | +110.9% | 398,631 | +85.1% | 0.00% | – |
Q1 2019 | $2,162,000 | +28.8% | 215,346 | +118.2% | 0.00% | – |
Q4 2018 | $1,678,000 | +51.7% | 98,714 | +56.9% | 0.00% | – |
Q3 2018 | $1,106,000 | – | 62,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 3,661,237 | $8,970,000 | 0.44% |
Alpine Global Management, LLC | 370,000 | $907,000 | 0.21% |
DELTEC ASSET MANAGEMENT LLC | 460,500 | $1,128,000 | 0.17% |
IHT Wealth Management, LLC | 334,367 | $819,000 | 0.07% |
Redmile Group, LLC | 1,358,825 | $3,329,000 | 0.06% |
GPS Wealth Strategies Group, LLC | 58,025 | $142,000 | 0.04% |
Granahan Investment Management | 465,049 | $1,139,000 | 0.02% |
SEARLE & CO. | 20,000 | $49,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 402,300 | $986,000 | 0.02% |
Gladstone Institutional Advisory LLC | 53,500 | $131 | 0.01% |